The data in CDC’s 1999 Verstraeten study clearly inculpated thimerosal as the principle culprit behind the autism epidemic. Contemporary emails among CDC officials— obtained under the FOIA— and the transcripts from a secret 2000 meeting between government regulators and vaccine makers at Simpsonwood, Georgia, show HHS officials plotting to create phony studies to exonerate vaccines. CDC officials hired a Scandanavian, Poul Thorsen, giving him $10 million to create a series of fraudulent reports from Denmark. Thorsen dutifully produced the predetermined results but allegedly stole at least $1 million of the grant from CDC. He is now an international fugitive under Federal indictment and on HHS’s “Most Wanted” list. CDC continues to cite Thorsen’s studies as the bedrock for its claim that vaccines don’t cause autism.
The CDC is a major player in the vaccine marketplace, buying half of all childhood vaccines in the U.S. and then selling them to contracted public health agencies through the Vaccines for Children (VFC) Program, which pushes free and low-cost vaccines on indigent children. Over the past three decades, the CDC’s vaccine purchases have increased 15-fold as the average cost of fully vaccinating a child to age 18 rose from $100 to $2192—while vaccine companies have raked in the profits. The agency’s involvement with vaccine manufacturers also extends to patents, licensing agreements and collaboration on projects to develop new vaccines. In fact, the CDC and the National Institutes of Health (NIH) profit handsomely from their ownership or co-ownership with private sector partners of vaccine-related patents. Some of the key technologies underlying the development of the HPV vaccines Gardasil and Cervarix emerged from research patented by the NIH’s National Cancer Institute (NCI), which then licensed the technology to Merck, MedImmune and GlaxoSmithKline. By 2009, HPV licensing had become NIH’s top generator of royalty revenues. Gardasil is “perhaps the leading example of a new form of unconstrained government self-dealing, in arrangements whereby [HHS] can transfer technology to pharmaceutical partners, [and] simultaneously both approve and protect their partners’ technology licenses while also taking a cut of the profits.” It seems doubtful that agencies can remain impartial in the face of these profits.
This year, the fear mongering about measles has reached epidemic proportions in America. A day doesn’t go by without media outlets publishing angry articles and editorials spewing hatred toward a tiny minority of parents with unvaccinated children, who are being blamed for measles outbreaks. The remedy is always a call to track down, persecute and punish any parent whose child is not vaccinated. While most of the public conversation in the past two decades has been focused on children, who have suffered convulsions, encephalitis and encephalopathy after MMR vaccine reactions and become chronically ill and disabled, there hasn’t been much discussion about measles vaccine effectiveness or what measles was like before and after the vaccine was licensed in the mid-20th century. This is a special report on measles vaccine failures based on evidence published in the scientific and medical literature that is not being discussed in public conversations about measles vaccine policies and mandatory vaccination laws. When vaccine policy and law precedes the science, we all pay the price. People should not be forced to use vaccines that not only cause harm but also, clearly, fail to work as advertised.
After the U.S. Food and Drug Administration’s (FDA) approved Merck’s HPV-9 Gardasil vaccine for use in adults age 27 to 45 in 2018, the Centers for Disease Control’s (CDC) Advisory Committee on Immunization Practices (ACIP) of the Department of Health and Human Services (HHS) is evaluating whether to expand their current HPV vaccine recommendation to include this new age group. ACIP’s current recommendation is that boys and girls ages 9 through 15 should get two-doses of HPV-9. The “catch-up” vaccine schedule is a three- dose series for females above age 15 through age 27 and males above 15 years of age to 21 years of age, if not previously vaccinated with HPV vaccine. Should ACIP expand their recommendations for use of HPV-9 vaccine in the newly approved age group, the CDC won’t be alone in the push to increase the use of the HPV vaccine by children and adults in the U.S. During the September meeting of the National Vaccine Advisory Committee (NVAC), a federal advisory committee that makes recommendations to the National Vaccine Program Office (NVPO), the HHS Assistant Secretary ADM Brett Giroir M.D. emphasized that HHS supported the NVAC’s HPV vaccine recommendations published in June 2018. Dr. Giroir stated that increasing HPV vaccination in America would be a focus for HHS in 2019. The federal government’s focus on increasing the use recommendations for the HPV vaccine may result in a renewed effort by state legislators to introduce legislation in many states to mandate HPV vaccine for school entry.
Questions and suspicions have been raised in recent years about apparent collusion by the CDC and the Coca-Cola corporation, which would allow the marketing of their soft drinks while suppressing information linking those soft drinks to health problems such as diabetes and obesity. These questions and suspicions were pursued by a study published in the Milbank Quarterly January 2019. Its title is Public Meets Private: Conversations Between Coca-Cola and the CDC. Public health agency collusion that potentially benefits a producer of harmful foods or beverages is no small issue. The “conversations” in the title of the study were emails the authors were able to obtain. The Milbank Quarterly researchers considered this study relevant due to recently reported episodes of top CDC officials entertaining relationships with Coca- Cola executives. The concern is that makers of unhealthy food products are having inappropriate influences on the CDC. For example, one of the reported episodes that motivated this study was: "In 2016, Barbara Bowman, director of the CDC’s Division for Heart Disease and Stroke Prevention, resigned after emails between her and a former Coca-Cola executive were disclosed. [The emails] showed that Bowman had advised the former Coca-Cola and industry association executive on how to influence the director-general of the World Health Organization (WHO) to stop promoting taxes on sugar."
CDC Lists Top Gardasil Vaccine “Champion” Doctors and Clinics in the U.S. Giving the Most HPV Vaccines
As we reported at the end of last month (December 2018), our #1 topic on Health Impact News in terms of readership is the Gardasil vaccine scandal, which you will almost never read about in the U.S. corporate-sponsored "mainstream" media. Our top 2 stories in 2018 were about the Gardasil vaccine, and we published many other articles about Merck's HPV vaccine Gardasil, the only HPV vaccine licensed for sale in the U.S., including news reports about how they are expanding their market by going into China, and obtaining FDA approval to expand the vaccine to older adults. These efforts are netting billions of dollars in new wealth for Merck. And Merck is apparently not expanding their market alone. They are doing it with help from the U.S. government, which also owns patents and earns revenue from the sale of the vaccine. The U.S. Centers for Disease Control and Prevention (CDC) just recently promoted the top doctors and clinics in the U.S. giving out the most Gardasil vaccines as "Champions" on their government-funded website. Since Gardasil is the #1 topic Health Impact News readers are concerned about, we figured you would be interested in knowing who these top doctors and clinics are in the U.S. giving out the most Gardasil vaccines, and we have republished the list of "Champions" in this article.
National Vaccine Laws Routinely Ignored by Health Officials and Doctors Regarding Patient Information on Vaccine Risks
In 1986, Congress passed the National Childhood Vaccine Injury Act (NCVIA), a carefully crafted piece of legislation that gave vaccine manufacturers their dream come true: blanket immunity from liability for injuries resulting from childhood vaccines. Throwing a bone to the safety concerns of consumers, the Act also mandated that the Department of Health and Human Services (HHS) (via the CDC) develop and distribute educational materials to inform vaccine recipients and/or their parents about a given vaccine’s risks and benefits. The NCVIA stipulated that doctors give out the appropriate materials—currently called Vaccine Information Statements (VISs)—“prior to every dose of specific vaccines,” including before “each dose of a multi-dose series.” Early on, government documentation emphasized the importance of giving VISs every time a vaccine is administered because “the health status of the child could have changed”—and as an example of changes in health status, the CDC cited children with “evolving neurological disorder[s].” By 2005, however, researchers were calling attention to doctors’ frequent failure to give out VISs, while also noting that the physicians who did distribute VISs “rarely initiated discussions regarding contraindications to immunizations.” To rectify the situation, the same authors carried out a CDC-coordinated evaluation in 2007 and proposed revisions “that would alert the physician to the need to use the VIS.” Neither the CDC nor state-level officials endorsed the proposed revisions. What appears to matter most to the CDC is that health care providers use “every opportunity to administer appropriate vaccines,” and informing patients about the potential risks to receiving vaccines is counter productive to that goal.
After four long years, Dr. Brian Hooker’s reanalysis of the CDC’s MMR-autism data from the original Destefano et al. 2004 Pediatrics paper has been republished in the Winter 2018 Edition of the Journal of American Physicians and Surgeons. The data, when properly analyzed, using the CDC’s own study protocol, show a strong, statistically significant relationship between the timing of the first MMR vaccine and autism, specifically in African American males. In addition, a relationship also exists in the timing of the MMR vaccine and those individuals who were diagnosed with autism without mental retardation. These relationships call into question the conclusion of the original Destefano et al. 2004 paper which dismissed a connection between the MMR vaccine and autism.
The US Centers for Disease Control and Prevention (CDC) recommends that everyone aged six months and up, including pregnant women, get an annual influenza vaccine. The two fundamental assumptions underlying the CDC’s policy are that vaccination reduces transmission of the virus and reduces the risk of potentially deadly complications. Yet multiple reviews of the scientific literature have concluded that there is no good scientific evidence to support the CDC’s claims. Notwithstanding the science, to increase demand for the pharmaceutical companies’ influenza vaccine products, the CDC makes use of fear marketing, asserting as fact that tens of thousands of people die each year from the flu, even though the CDC’s numbers are actually estimates that are controversial because they are based on dubious assumptions that appear to result in a great overestimation of the negative impact of influenza on societal health. The primary justification for the CDC’s flu vaccine policy is the assumption that it significantly reduces the mortality rate among people aged 65 and older, the group at highest risk of potentially deadly complications from the flu. The CDC declares to the public that the vaccine does so as though this was a scientifically proven fact. Yet, the reality is that the CDC’s bold claim that the vaccine greatly reduces the risk of death among the elderly has been thoroughly discredited by the scientific community.
American Cancer Society Seeks $11 Billion to Pursue an 80% Gardasil Vaccination Rate Among U.S. Children
The American Cancer Society (ACS) has set an aggressive goal to achieve an 80 percent uptake rate among American children with two doses human papillomavirus (HPV) vaccine by 2026. To gain that coverage, 14 million more preteen children would need to complete the two-dose series, for a total of 57.62 million doses above and beyond the number of vaccinations given to date. HPV vaccine is one of the most expensive vaccines on the CDC recommended childhood vaccine schedule, costing a pricey $168 to $204 per dose, with Merck being the sole producer of HPV vaccine (Gardasil) in the U.S. Although U.S. health officials have continued to deny a causal connection, Japanese researchers have pointed out that the temporal association with post-Gardasil clinical symptoms such as “chronic regional pain syndrome, orthostatic intolerance, and/or cognitive dysfunction” suggests a causal relationship with the vaccine. Other health issues associated with HPV vaccination include nervous and immune system disorders such as postural orthostatic tachycardia syndrome (POTS), chronic fatigue syndrome, blood clots, acute respiratory failure and cardiac arrest. Also widely reported are menstrual abnormalities and premature ovarian failure. Using the MedAlerts search engine, as of April 30, 2018, the federal Vaccine Adverse Events Reporting System (VAERS) contained more than 58,992 reports of HPV vaccine reactions, hospitalizations, injuries and deaths including 430 related deaths, 794 hospitalizations, and 2,773 disabling conditions. Over 45 percent of the reported serious adverse events occurred in children and teens 12-17 years of age.